Carbonic Anhydrase Inhibitor class drugs

12 results
  • acetazolamide

    (Acetazolamide)
    Aarkish Pharmaceuticals NJ Inc.
    Acetazolamide is indicated as adjunctive treatment for edema related to congestive heart failure, drug-induced edema, centrencephalic epilepsies, and glaucoma. It also helps prevent or alleviate acute mountain sickness symptoms in climbers, especially during rapid ascents.
  • acetazolamide

    (Acetazolamide)
    Eywa Pharma Inc
    Acetazolamide is indicated as adjunctive treatment for edema from congestive heart failure and drug-induced causes, certain types of epilepsy, various glaucoma types, and for preventing symptoms of acute mountain sickness in climbers.
  • acetazolamide

    (Acetazolamide)
    Ingenus Pharmaceuticals, LLC
    Acetazolamide is indicated for adjunctive treatment of chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperative management in acute angle-closure glaucoma to lower intraocular pressure. It also helps prevent or alleviate symptoms of acute mountain sickness during gradual ascent.
  • acetazolamide

    (acetazolamide)
    Accord Healthcare Inc.
    Acetazolamide extended-release capsules are indicated as adjunctive treatment for chronic simple glaucoma, secondary glaucoma, and preoperative management of acute angle-closure glaucoma to lower intraocular pressure. They are also used to prevent or alleviate symptoms of acute mountain sickness during gradual ascent.
  • acetazolamide

    (Acetazolamide)
    Ajanta Pharma USA Inc.
    Acetazolamide is indicated as an adjunctive treatment for edema related to congestive heart failure and drug use, various forms of epilepsy, chronic and secondary glaucoma, and to lower intraocular pressure preoperatively in acute angle-closure glaucoma. It also prevents or alleviates symptoms of acute mountain sickness.
  • acetazolamide extended-release

    (Acetazolamide extended-release)
    Micro Labs Limited
    Acetazolamide extended-release capsules are indicated as adjunctive treatment for chronic simple glaucoma, secondary glaucoma, and preoperatively for acute angle-closure glaucoma to lower intraocular pressure. They also prevent or alleviate symptoms of acute mountain sickness during gradual ascent.
  • cosopt pf

    (dorzolamide hydrochloride and timolol maleate)
    Thea Pharma Inc.
    COSOPT® PF is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who do not adequately respond to beta-blockers. It is typically administered twice daily and offers a different IOP-lowering effect compared to standard therapies.
  • dorzolamide hydrochloride

    (Dorzolamide Hydrochloride)
    Gland Pharma Limited
    Dorzolamide Hydrochloride Ophthalmic Solution is indicated for treating elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
  • dorzolamide hydrochloride and timolol maleate

    (Dorzolamide Hydrochloride and Timolol Maleate)
    Sandoz Inc
    Dorzolamide hydrochloride and timolol maleate ophthalmic solution is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who do not adequately respond to beta-blockers. It is administered twice daily.